A game-changing biochemical and biophysical analyzer
Superceuticals, a trailblazer in healthcare innovation, proudly announces the launch of its revolutionary SC-AN 2.4 product. With an unwavering commitment to transforming healthcare in India, Superceuticals introduces this state-of-the-art diagnostic and telemedicine marvel that is set to redefine the healthcare landscape.
SC-AN 2.4 is a game-changing biochemical and biophysical analyzer, employing advanced technologies such as electrical impedance, amperometry, voltammetry, cell counting, photometry, and immunological reactions with fluorescence assay. This kiosk-based system is capable of running over 85 parameters and delivering clinically validated reports within minutes, significantly reducing diagnosis time and human errors.
SC-AN 2.4 boasts an impressive array of key features designed to revolutionize healthcare. One of its standout capabilities is its ability to provide instant reports, delivering results in as little as 10 minutes, ensuring swift and efficient patient care. Powered by cutting-edge technology, this innovative system goes beyond conventional diagnostics, incorporating digital health records to enhance the overall patient experience. In addition to its clinical benefits, SC-AN 2.4 also champions environmental sustainability by reducing sample handling, reagent usage, and the need for transportation.
Furthermore, this advanced diagnostic solution simplifies the sample collection process, requiring only a minimal amount of blood obtained through a straightforward finger prick, making it more patient-friendly. What sets SC-AN 2.4 apart is its accessibility, as it does not necessitate extensive medical training for operation, enabling a broader range of personnel to utilize its capabilities effectively. SC-AN 2.4 upholds the highest standards of accuracy, instilling confidence in the reliability of its results. Finally, its cost-effective nature translates to substantial savings for both patients and healthcare providers, emphasizing its role as a transformative force in modern healthcare.
Superceuticals Director Atman Jadon said, “At Superceuticals, we believe that healthcare and knowledge go hand in hand. SC-AN 2.4 not only enhances diagnostic capabilities but also serves as an information system, disseminating critical healthcare information as needed. Our mobile application, complementing the system, curates a list of preferred medical providers and best treatment practices through artificial intelligence.”
The recent launch of SC-AN 2.4 at Sonipat signifies a significant step towards automated, quality healthcare, providing patients with a holistic healthcare environment while saving them time and resources.
Superceuticals’ commitment to indigenous innovation aligns with the “Make in India” initiative, and the organization is proud to be an integral part of the AIC IIT Delhi ecosystem, recognized by DPIIT.
